0001140361-23-057390.txt : 20231212 0001140361-23-057390.hdr.sgml : 20231212 20231212205109 ACCESSION NUMBER: 0001140361-23-057390 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231207 FILED AS OF DATE: 20231212 DATE AS OF CHANGE: 20231212 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Woods Keith CENTRAL INDEX KEY: 0001996804 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36829 FILM NUMBER: 231482792 MAIL ADDRESS: STREET 1: C/O X4 PHARMACEUTICALS INC. STREET 2: 61 NORTH BEACON STREET 4TH FLOOR CITY: BOSTON STATE: MA ZIP: 02134 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ROCKET PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001281895 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 350 FIFTH AVENUE STREET 2: SUITE 7530 CITY: NEW YORK STATE: NY ZIP: 10118 BUSINESS PHONE: 646-440-9100 MAIL ADDRESS: STREET 1: 350 FIFTH AVENUE STREET 2: SUITE 7530 CITY: NEW YORK STATE: NY ZIP: 10118 FORMER COMPANY: FORMER CONFORMED NAME: INOTEK PHARMACEUTICALS CORP DATE OF NAME CHANGE: 20040226 4 1 form4.xml X0508 4 2023-12-07 0001281895 ROCKET PHARMACEUTICALS, INC. RCKT 0001996804 Woods Keith C/O ROCKET PHARMACEUTICALS, INC. 9 CEDARBROOK DRIVE CRANBURY NJ 08512 true false Stock Option (Right to Buy) 26.3 2023-12-07 4 A 0 20522 0 A 2033-12-07 Common Stock 20522 20522 D Stock Option (Right to Buy) 26.3 2023-12-07 4 A 0 11960 0 A 2033-12-07 Common Stock 11960 11960 D This option represents a right to purchase a total of 20,522 shares of the Issuer's common stock, which will vest in equal monthly installments over a three-year period, such that all of the shares underlying this option will be fully vested on December 7, 2026. This option represents a right to purchase a total of 11,960 shares of the Issuer's common stock, which will fully vest on December 7, 2024. /s/ Martin Wilson, as attorney-in-fact for Keith Woods 2023-12-12